On 21 November 2023, following its spin-off from Novartis on 4 October 2023, Sandoz, a global leader in the generics and biosimilars markets successfully placed EUR 2.0 billion senior guaranteed Eurobonds and CHF 750 million senior bonds. The Eurobonds are issued in three tranches with EUR 700 million 3.97% bonds due 2027, EUR 700 million 4.22% bonds due 2030 and EUR 600 million 4.50% bonds due 2033 whereas the CHF bonds were issued in two tranches with CHF 400 million 2.125% bonds due in 2026 and CHF 350 million 2.600% bonds due in 2031. The Eurobonds are issued by Sandoz Finance B.V. and guaranteed by Sandoz Group Ltd (SIX: SDZ). BNP Paribas, J.P. Morgan and Mizuho acted as Joint Active Bookrunners for the Eurobonds and BNP Paribas and UBS acted as Joint Lead Managers for the CHF tranches.